HomeVRDN • NASDAQ
add
Viridian Therapeutics Inc
Previous close
$13.81
Day range
$13.95 - $14.63
Year range
$10.93 - $28.35
Market cap
930.53M USD
Avg Volume
817.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 72.00K | -31.43% |
Operating expense | 32.99M | 234.82% |
Net income | -66.86M | -46.03% |
Net profit margin | -92.86K | -112.96% |
Earnings per share | -1.35 | -19.47% |
EBITDA | -71.33M | -45.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 477.37M | 12.44% |
Total assets | 490.42M | 12.72% |
Total liabilities | 48.40M | 20.92% |
Total equity | 442.02M | — |
Shares outstanding | 62.77M | — |
Price to book | 3.17 | — |
Return on assets | -43.63% | — |
Return on capital | -46.43% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -66.86M | -46.03% |
Cash from operations | -38.00M | -11.63% |
Cash from investing | -169.71M | 6.03% |
Cash from financing | 198.94M | 664.75% |
Net change in cash | -8.77M | 95.35% |
Free cash flow | -14.01M | 23.07% |
About
Founded
2010
Headquarters
Website
Employees
96